🔴 Breaking
Tuesday, September 15, 2026

Discover Categories

Latest News

See All
Gold Miners Mark Two Decades of Trading
Ops Briefs

Gold Miners Mark Two Decades of Trading

VanEck's Gold Miners ETF marks 20 years of tracking gold mining companies, highlighting gold's role in America's monetary…

· July 20, 2026
Gold Marks Two Decades of GDX Trading
Cash Health

Gold Marks Two Decades of GDX Trading

Gold miners ETF GDX marks two decades of trading, giving investors a way to own a diversified basket…

· July 19, 2026
Investors Cautioned as Certain Stocks Falter
Scale Steps

Investors Cautioned as Certain Stocks Falter

Low yield stocks are under scrutiny as investors seek at least 3.5% dividends; Delta Air Lines, Starbucks and…

· July 18, 2026
S&P 500 Drops Below 50-Day Moving Average
Ops Briefs

S&P 500 Drops Below 50-Day Moving Average

The S&P 500 dropped below its 50-day moving average, signaling a short-term shift. Learn what this key technical…

· July 18, 2026
T Rowe Price launches crypto investment product
Cash Health

T Rowe Price launches crypto investment product

T Rowe Price launches crypto investment product for spot exposure to multiple digital tokens like Bitcoin and Ethereum.

· July 17, 2026
Direxion Launches Daily SK Hynix Bull 2X ETF
Scale Steps

Direxion Launches Daily SK Hynix Bull 2X ETF

Direxion Launches Daily SK Hynix Bull 2X ETF offering leveraged exposure. Discover how SKHL provides amplified gains on…

· July 16, 2026
Coco Explores RANK ETF Analyst and Momentum Approach
Scale Steps

Coco Explores RANK ETF Analyst and Momentum Approach

Discover how Brian Coco explores the RANK ETF analyst and momentum approach, blending top analyst picks with price…

· July 15, 2026
Small caps seen as undervalued opportunity
Ops Briefs

Small caps seen as undervalued opportunity

Small-cap stocks offer undervalued opportunities with strong growth potential, trading at steep discounts compared to the broader market.

· July 14, 2026
Big Pharma’s patent cliff sparks biotech deal rush
Scale Steps

Big Pharma’s patent cliff sparks biotech deal rush

Big Pharma's $300 billion patent cliff is driving a biotech deal rush as drugmakers scramble to buy new…

· July 13, 2026
Real Estate ETFs Beat Market Despite Rising Rates
Scale Steps

Real Estate ETFs Beat Market Despite Rising Rates

Real estate ETFs outpace the market despite rising rates. Discover how funds like XLRE and VNQ beat the…

· July 12, 2026